Market Analysis and Insights: Global Preclinical CRO Market
The global Preclinical CRO market size is projected to reach US$ 4880.9 million by 2028, from US$ 3452.8 million in 2021, at a CAGR of 4.6% during 2022-2028.
Fully considering the economic change by this health crisis, Security Evaluation Service accounting for % of the Preclinical CRO global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical Industry segment is altered to an % CAGR throughout this forecast period.
China Preclinical CRO market size is valued at US$ million in 2021, while the North America and Europe Preclinical CRO are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Preclinical CRO landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preclinical CRO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preclinical CRO market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preclinical CRO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preclinical CRO market.
Global Preclinical CRO Scope and Market Size
Preclinical CRO market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Preclinical CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- Security Evaluation Service
- Pharmacokinetic Research
- Pharmacodynamic Research
- Other
Segment by Application
- Pharmaceutical Industry
- Biotechnology
By Company
- Charles River
- Eurofins Scientific
- Wuxi AppTec
- Pharmaceutical Product Development (PPD), LLC
- ICON Plc.
- Labcorp
- CRL
- Crown Bioscience
- Taconic Biosciences
- Covance
- EVOTEC
- The Jackson Laboratory
- MI Bioresearch
- Champion Oncology
- Xentech
- Living Tumor Laboratory
- JOINN Lab
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Preclinical CRO Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Security Evaluation Service
- 1.2.3 Pharmacokinetic Research
- 1.2.4 Pharmacodynamic Research
- 1.2.5 Other
- 1.3 Market by Application
- 1.3.1 Global Preclinical CRO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Pharmaceutical Industry
- 1.3.3 Biotechnology
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Preclinical CRO Market Perspective (2017-2028)
- 2.2 Preclinical CRO Growth Trends by Region
- 2.2.1 Preclinical CRO Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Preclinical CRO Historic Market Size by Region (2017-2022)
- 2.2.3 Preclinical CRO Forecasted Market Size by Region (2023-2028)
- 2.3 Preclinical CRO Market Dynamics
- 2.3.1 Preclinical CRO Industry Trends
- 2.3.2 Preclinical CRO Market Drivers
- 2.3.3 Preclinical CRO Market Challenges
- 2.3.4 Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Preclinical CRO Players by Revenue
- 3.1.1 Global Top Preclinical CRO Players by Revenue (2017-2022)
- 3.1.2 Global Preclinical CRO Revenue Market Share by Players (2017-2022)
- 3.2 Global Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Preclinical CRO Revenue
- 3.4 Global Preclinical CRO Market Concentration Ratio
- 3.4.1 Global Preclinical CRO Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Preclinical CRO Revenue in 2021
- 3.5 Preclinical CRO Key Players Head office and Area Served
- 3.6 Key Players Preclinical CRO Product Solution and Service
- 3.7 Date of Enter into Preclinical CRO Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Preclinical CRO Breakdown Data by Type
- 4.1 Global Preclinical CRO Historic Market Size by Type (2017-2022)
- 4.2 Global Preclinical CRO Forecasted Market Size by Type (2023-2028)
5 Preclinical CRO Breakdown Data by Application
- 5.1 Global Preclinical CRO Historic Market Size by Application (2017-2022)
- 5.2 Global Preclinical CRO Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Preclinical CRO Market Size (2017-2028)
- 6.2 North America Preclinical CRO Market Size by Type
- 6.2.1 North America Preclinical CRO Market Size by Type (2017-2022)
- 6.2.2 North America Preclinical CRO Market Size by Type (2023-2028)
- 6.2.3 North America Preclinical CRO Market Share by Type (2017-2028)
- 6.3 North America Preclinical CRO Market Size by Application
- 6.3.1 North America Preclinical CRO Market Size by Application (2017-2022)
- 6.3.2 North America Preclinical CRO Market Size by Application (2023-2028)
- 6.3.3 North America Preclinical CRO Market Share by Application (2017-2028)
- 6.4 North America Preclinical CRO Market Size by Country
- 6.4.1 North America Preclinical CRO Market Size by Country (2017-2022)
- 6.4.2 North America Preclinical CRO Market Size by Country (2023-2028)
- 6.4.3 U.S.
- 6.4.4 Canada
7 Europe
- 7.1 Europe Preclinical CRO Market Size (2017-2028)
- 7.2 Europe Preclinical CRO Market Size by Type
- 7.2.1 Europe Preclinical CRO Market Size by Type (2017-2022)
- 7.2.2 Europe Preclinical CRO Market Size by Type (2023-2028)
- 7.2.3 Europe Preclinical CRO Market Share by Type (2017-2028)
- 7.3 Europe Preclinical CRO Market Size by Application
- 7.3.1 Europe Preclinical CRO Market Size by Application (2017-2022)
- 7.3.2 Europe Preclinical CRO Market Size by Application (2023-2028)
- 7.3.3 Europe Preclinical CRO Market Share by Application (2017-2028)
- 7.4 Europe Preclinical CRO Market Size by Country
- 7.4.1 Europe Preclinical CRO Market Size by Country (2017-2022)
- 7.4.2 Europe Preclinical CRO Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Preclinical CRO Market Size (2017-2028)
- 8.2 Asia-Pacific Preclinical CRO Market Size by Type
- 8.2.1 Asia-Pacific Preclinical CRO Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Preclinical CRO Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Preclinical CRO Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Preclinical CRO Market Size by Application
- 8.3.1 Asia-Pacific Preclinical CRO Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Preclinical CRO Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Preclinical CRO Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Preclinical CRO Market Size by Region
- 8.4.1 Asia-Pacific Preclinical CRO Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Preclinical CRO Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Preclinical CRO Market Size (2017-2028)
- 9.2 Latin America Preclinical CRO Market Size by Type
- 9.2.1 Latin America Preclinical CRO Market Size by Type (2017-2022)
- 9.2.2 Latin America Preclinical CRO Market Size by Type (2023-2028)
- 9.2.3 Latin America Preclinical CRO Market Share by Type (2017-2028)
- 9.3 Latin America Preclinical CRO Market Size by Application
- 9.3.1 Latin America Preclinical CRO Market Size by Application (2017-2022)
- 9.3.2 Latin America Preclinical CRO Market Size by Application (2023-2028)
- 9.3.3 Latin America Preclinical CRO Market Share by Application (2017-2028)
- 9.4 Latin America Preclinical CRO Market Size by Country
- 9.4.1 Latin America Preclinical CRO Market Size by Country (2017-2022)
- 9.4.2 Latin America Preclinical CRO Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Preclinical CRO Market Size (2017-2028)
- 10.2 Middle East & Africa Preclinical CRO Market Size by Type
- 10.2.1 Middle East & Africa Preclinical CRO Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Preclinical CRO Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Preclinical CRO Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Preclinical CRO Market Size by Application
- 10.3.1 Middle East & Africa Preclinical CRO Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Preclinical CRO Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Preclinical CRO Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Preclinical CRO Market Size by Country
- 10.4.1 Middle East & Africa Preclinical CRO Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Preclinical CRO Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Charles River
- 11.1.1 Charles River Company Details
- 11.1.2 Charles River Business Overview
- 11.1.3 Charles River Preclinical CRO Introduction
- 11.1.4 Charles River Revenue in Preclinical CRO Business (2017-2022)
- 11.1.5 Charles River Recent Developments
- 11.2 Eurofins Scientific
- 11.2.1 Eurofins Scientific Company Details
- 11.2.2 Eurofins Scientific Business Overview
- 11.2.3 Eurofins Scientific Preclinical CRO Introduction
- 11.2.4 Eurofins Scientific Revenue in Preclinical CRO Business (2017-2022)
- 11.2.5 Eurofins Scientific Recent Developments
- 11.3 Wuxi AppTec
- 11.3.1 Wuxi AppTec Company Details
- 11.3.2 Wuxi AppTec Business Overview
- 11.3.3 Wuxi AppTec Preclinical CRO Introduction
- 11.3.4 Wuxi AppTec Revenue in Preclinical CRO Business (2017-2022)
- 11.3.5 Wuxi AppTec Recent Developments
- 11.4 Pharmaceutical Product Development (PPD), LLC
- 11.4.1 Pharmaceutical Product Development (PPD), LLC Company Details
- 11.4.2 Pharmaceutical Product Development (PPD), LLC Business Overview
- 11.4.3 Pharmaceutical Product Development (PPD), LLC Preclinical CRO Introduction
- 11.4.4 Pharmaceutical Product Development (PPD), LLC Revenue in Preclinical CRO Business (2017-2022)
- 11.4.5 Pharmaceutical Product Development (PPD), LLC Recent Developments
- 11.5 ICON Plc.
- 11.5.1 ICON Plc. Company Details
- 11.5.2 ICON Plc. Business Overview
- 11.5.3 ICON Plc. Preclinical CRO Introduction
- 11.5.4 ICON Plc. Revenue in Preclinical CRO Business (2017-2022)
- 11.5.5 ICON Plc. Recent Developments
- 11.6 Labcorp
- 11.6.1 Labcorp Company Details
- 11.6.2 Labcorp Business Overview
- 11.6.3 Labcorp Preclinical CRO Introduction
- 11.6.4 Labcorp Revenue in Preclinical CRO Business (2017-2022)
- 11.6.5 Labcorp Recent Developments
- 11.7 CRL
- 11.7.1 CRL Company Details
- 11.7.2 CRL Business Overview
- 11.7.3 CRL Preclinical CRO Introduction
- 11.7.4 CRL Revenue in Preclinical CRO Business (2017-2022)
- 11.7.5 CRL Recent Developments
- 11.8 Crown Bioscience
- 11.8.1 Crown Bioscience Company Details
- 11.8.2 Crown Bioscience Business Overview
- 11.8.3 Crown Bioscience Preclinical CRO Introduction
- 11.8.4 Crown Bioscience Revenue in Preclinical CRO Business (2017-2022)
- 11.8.5 Crown Bioscience Recent Developments
- 11.9 Taconic Biosciences
- 11.9.1 Taconic Biosciences Company Details
- 11.9.2 Taconic Biosciences Business Overview
- 11.9.3 Taconic Biosciences Preclinical CRO Introduction
- 11.9.4 Taconic Biosciences Revenue in Preclinical CRO Business (2017-2022)
- 11.9.5 Taconic Biosciences Recent Developments
- 11.10 Covance
- 11.10.1 Covance Company Details
- 11.10.2 Covance Business Overview
- 11.10.3 Covance Preclinical CRO Introduction
- 11.10.4 Covance Revenue in Preclinical CRO Business (2017-2022)
- 11.10.5 Covance Recent Developments
- 11.11 EVOTEC
- 11.11.1 EVOTEC Company Details
- 11.11.2 EVOTEC Business Overview
- 11.11.3 EVOTEC Preclinical CRO Introduction
- 11.11.4 EVOTEC Revenue in Preclinical CRO Business (2017-2022)
- 11.11.5 EVOTEC Recent Developments
- 11.12 The Jackson Laboratory
- 11.12.1 The Jackson Laboratory Company Details
- 11.12.2 The Jackson Laboratory Business Overview
- 11.12.3 The Jackson Laboratory Preclinical CRO Introduction
- 11.12.4 The Jackson Laboratory Revenue in Preclinical CRO Business (2017-2022)
- 11.12.5 The Jackson Laboratory Recent Developments
- 11.13 MI Bioresearch
- 11.13.1 MI Bioresearch Company Details
- 11.13.2 MI Bioresearch Business Overview
- 11.13.3 MI Bioresearch Preclinical CRO Introduction
- 11.13.4 MI Bioresearch Revenue in Preclinical CRO Business (2017-2022)
- 11.13.5 MI Bioresearch Recent Developments
- 11.14 Champion Oncology
- 11.14.1 Champion Oncology Company Details
- 11.14.2 Champion Oncology Business Overview
- 11.14.3 Champion Oncology Preclinical CRO Introduction
- 11.14.4 Champion Oncology Revenue in Preclinical CRO Business (2017-2022)
- 11.14.5 Champion Oncology Recent Developments
- 11.15 Xentech
- 11.15.1 Xentech Company Details
- 11.15.2 Xentech Business Overview
- 11.15.3 Xentech Preclinical CRO Introduction
- 11.15.4 Xentech Revenue in Preclinical CRO Business (2017-2022)
- 11.15.5 Xentech Recent Developments
- 11.16 Living Tumor Laboratory
- 11.16.1 Living Tumor Laboratory Company Details
- 11.16.2 Living Tumor Laboratory Business Overview
- 11.16.3 Living Tumor Laboratory Preclinical CRO Introduction
- 11.16.4 Living Tumor Laboratory Revenue in Preclinical CRO Business (2017-2022)
- 11.16.5 Living Tumor Laboratory Recent Developments
- 11.17 JOINN Lab
- 11.17.1 JOINN Lab Company Details
- 11.17.2 JOINN Lab Business Overview
- 11.17.3 JOINN Lab Preclinical CRO Introduction
- 11.17.4 JOINN Lab Revenue in Preclinical CRO Business (2017-2022)
- 11.17.5 JOINN Lab Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer